Header

UZH-Logo

Maintenance Infos

Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation


Wüthrich, Rudolf P; Cicvara, Snjezana; Ambühl, Patrice M; Binswanger, Ulrich (2000). Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation. Nephrology, Dialysis, Transplantation, 15(8):1228-1231.

Abstract

Background. In the first year after renal allograft transplantation, triple therapy immunosuppression with cyclosporin (CsA), prednisone (P), and mycophenolate mofetil (MMF) is superior to a triple therapy treatment that includes azathioprine (AZA) instead of MMF. Whether long‐term treatment with CsA‐P‐MMF is better than treatment with CsA‐P‐AZA is a matter of debate, as 3‐year graft survival is similar in MMF‐ and AZA‐treated patients. The purpose of the present study was to examine the short‐term effect of changing MMF to AZA in low‐risk renal allograft recipients 6 months after transplantation. Method. This was a randomized, open‐label single‐centre study, recruiting 48 low risk renal allograft recipients on CsA‐P‐MMF therapy 6 months after transplantation, comparing the outcome with continued MMF treatment (2 g b.i.d.) (group A, n=22) or switching MMF to AZA (1 mg/kg) treatment (group B, n=26). Results. The outcome after a 6‐months follow‐up of patients in group A and group B was similar. Treatment failure rates (defined as clinically diagnosed acute rejection episodes) were 4.5% in group A and 3.8% in group B. There were no patient deaths and no graft failures during the 6‐months observation period. Graft function was excellent and similar in both groups. Conclusion. Replacing MMF with AZA 6 months after transplantation in low‐risk renal allograft recipients is safe and is not associated with altered graft function in the short term

Abstract

Background. In the first year after renal allograft transplantation, triple therapy immunosuppression with cyclosporin (CsA), prednisone (P), and mycophenolate mofetil (MMF) is superior to a triple therapy treatment that includes azathioprine (AZA) instead of MMF. Whether long‐term treatment with CsA‐P‐MMF is better than treatment with CsA‐P‐AZA is a matter of debate, as 3‐year graft survival is similar in MMF‐ and AZA‐treated patients. The purpose of the present study was to examine the short‐term effect of changing MMF to AZA in low‐risk renal allograft recipients 6 months after transplantation. Method. This was a randomized, open‐label single‐centre study, recruiting 48 low risk renal allograft recipients on CsA‐P‐MMF therapy 6 months after transplantation, comparing the outcome with continued MMF treatment (2 g b.i.d.) (group A, n=22) or switching MMF to AZA (1 mg/kg) treatment (group B, n=26). Results. The outcome after a 6‐months follow‐up of patients in group A and group B was similar. Treatment failure rates (defined as clinically diagnosed acute rejection episodes) were 4.5% in group A and 3.8% in group B. There were no patient deaths and no graft failures during the 6‐months observation period. Graft function was excellent and similar in both groups. Conclusion. Replacing MMF with AZA 6 months after transplantation in low‐risk renal allograft recipients is safe and is not associated with altered graft function in the short term

Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

5 downloads since deposited on 25 Sep 2018
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:National licences > 142-005
Dewey Decimal Classification:570 Life sciences; biology
Language:English
Date:1 August 2000
Deposited On:25 Sep 2018 15:23
Last Modified:04 Oct 2018 11:40
Publisher:Oxford University Press
ISSN:0931-0509
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/ndt/15.8.1228
Related URLs:https://www.swissbib.ch/Search/Results?lookfor=nationallicenceoxford101093ndt1581228 (Library Catalogue)

Download

Download PDF  'Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 64kB
View at publisher